Bayesian Network Meta-Comparison of Maintenance Treatments for Stage IIIb/IV Non-Small-Cell Lung Cancer (NSCLC) Patients With Good Performance Status Not Progressing After First-Line Induction Chemotherapy: Results by Performance Status, EGFR Mutation, Histology and Response to Previous Induction

European Journal of Cancer - United Kingdom
doi 10.1016/j.ejca.2015.07.007
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Elsevier BV

Related search

PD2.06 (Also Presented as P1.41): Bayesian Network Meta-Comparison of Maintenance Treatments for Advanced Non-Small-Cell Lung Cancer (NSCLC) Patients

Journal of Thoracic Oncology
MedicineOncologyRespiratory MedicinePulmonary
2016English

The Status of Immunosuppression in Patients With Stage IIIB or IV Non-Small-Cell Lung Cancer Correlates With the Clinical Characteristics and Response to Chemotherapy

OncoTargets and Therapy
OncologyPharmacology
2017English

Correlation Between KRAS Mutation Status and Response to Chemotherapy in Patients With Advanced Non-Small Cell Lung Cancer☆

Lung Cancer
Cancer ResearchOncologyRespiratory MedicinePulmonary
2016English

EGFR Mutations Status for Non-Small-Cell Lung Cancer Patients

Sveikatos mokslai
2016English

EGFR Mutation Status in Tunisian Non-Small-Cell Lung Cancer Patients Evaluated by Mutation-Specific Immunohistochemistry

BMC Pulmonary Medicine
PulmonaryRespiratory Medicine
2018English

The Impact of Rescue or Maintenance Therapy With EGFR TKIs for Stage IIIb-IV Non-Squamous Non-Small-Cell Lung Cancer Patients Requiring Mechanical Ventilation

BMC Anesthesiology
AnesthesiologyPain Medicine
2014English

P2.01-80 Performance Status and Resource Utilization in Patients Receiving Palliaitve Care With Stage IV Non-Small Cell Lung Cancer

Journal of Thoracic Oncology
MedicineOncologyRespiratory MedicinePulmonary
2018English

Atezolizumab for the First-Line Treatment of Non-Small Cell Lung Cancer (NSCLC): Current Status and Future Prospects

Frontiers in Oncology
Cancer ResearchOncology
2018English

Induction Chemoradiotherapy Versus Induction Chemotherapy for Potentially Resectable Stage IIIA (N2) Non-Small Cell Lung Cancer: A Systematic Review and Meta-Analysis

Journal of Thoracic Disease
PulmonaryRespiratory Medicine
2018English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy